Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Dec 1;17(23):6651-5.
doi: 10.1016/j.bmcl.2007.09.010. Epub 2007 Sep 7.

N-Benzyl-3-sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli

Affiliations
Comparative Study

N-Benzyl-3-sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli

Shubhasish Mukherjee et al. Bioorg Med Chem Lett. .

Abstract

A new small molecule inhibitor of bacterial cell division has been discovered using a high-throughput screen in Escherichia coli. Although the lead screening hit (534F6) exhibited modest inhibition of the GTPase activity of FtsZ (20+/-5% at 100microM of compound), a primary target for bacterial cell division inhibitors, several analogs caused potent bacterial growth inhibition with negligible antagonism of FtsZ GTPase activity. A library of analogs has been prepared and several alkyne-tagged photoaffinity probes have been synthesized for use in experiments to elucidate the primary target of this compound.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lead compound (534F6) from phenotypic HTS for compounds that induce lethal filamentation in E. coli.
Figure 2
Figure 2
E. coli DRC39 treated for 15h with A) 5 μM 14 15.
Scheme 1
Scheme 1
Synthesis of the enantiomers of 534F6
Scheme 2
Scheme 2
Solid- and solution-phase synthesis of analogs of 534F6.
Scheme 3
Scheme 3
Synthesis of 19, a benzophenone derivative of 534F6.
Scheme 4
Scheme 4
Synthesis of 23a and 23b, alkyne-tagged derivatives of 5a.
Scheme 5
Scheme 5
Synthesis of 29, an alkyne-tagged and azide-appended derivative of 534F6.

References

    1. Walsh C. Nature Reviews Microbiology. 2003;1:65–70. - PubMed
    1. Walsh C. Antibiotics: Actions, Origins, Resistance. ASM Press; Washington DC: 2003.
    1. Romberg L, Levin PA. Ann. Rev. Microbiol. 2003;57:125–154. - PMC - PubMed
    2. Margolin W. Nat. Rev. Mol. Cell Biol. 2005;6:862–871. - PMC - PubMed
    3. Dajkovic A, Lutkenhaus J. J. Mol. Microbiol. Biotechnol. 2006;11:140–51. - PubMed
    1. White EL, Suling WJ, Ross LJ, Seitz LE, Reynolds RC. J. Antimicrob. Chemother. 2002;50:111–114. - PubMed
    2. Reynolds RC, Srivastava S, Ross LJ, Suling WJ, White EL. Bioorg. Med. Chem. Lett. 2004;14:3161–3164. - PubMed
    3. Wang J, Galgoci A, Kodali S, Herath KB, Jayasuriya H, Dorso K, Vicente F, Gonzalez A, Cully D, Bramhill D, Singh S. J. Biol. Chem. 2003;278:44424–44428. - PubMed
    4. Margalit DN, Romberg L, Mets RB, Hebert AM, Mitchison TJ, Kirschner MW, RayChaudhuri D. Proc. Natl. Acad. Sci. U. S. A. 2004;101:11821–11826. - PMC - PubMed
    5. Urgaonkar S, Pierre H. S. La, Meir I, Lund H, Chaudhuri D. Ray, Shaw JT. Org. Lett. 2005;7:5609–5612. - PMC - PubMed
    6. Stokes NR, et al. J. Biol. Chem. 2005;280:39709–39715. - PubMed
    7. Jaiswal R, Beuria TK, Mohan R, Mahajan SK, Panda D. Biochemistry. 2007;46:4211–4220. - PubMed
    1. Vollmer W. Appl. Microbiol. Biotechnol. 2006;73:37–47. - PubMed

Publication types

MeSH terms